3,487.66p+59.66 (+1.74%)27 Jun 2022, 12:23
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Dechra Pharmaceuticals PLC Fundamentals

Company NameDechra Pharmaceuticals PLCLast Updated2022-06-27
IndustryDrug Manufacturers - GeneralSectorHealthcare
Shares in Issue108.389 mMarket Cap£3.77 bn
PE Ratio51.28Dividend per Share£0.35
Dividend Yield1.21Dividend Cover1.45
EPS£0.51EPS Growth (%)0.33
PEG0DPS Growth (%)0.0840
Debt Ratio0.2690Debt Equity Ratio0.4908
Asset Equity Ratio1.8427Cash Equity Ratio0.1936
Quick Ratio1.6200Current Ratio2.91
Price To Book Value5.8140ROCE0

Dechra Pharmaceuticals PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Dechra Pharmaceuticals PLC Company Financials

Tangible Assets£87.00 m£76.40 m£58.40 m
Intangible Assets£715.80 m£692.20 m£680.60 m
Investments£17.10 m£17.40 m£10.10 m
Total Fixed Assets£821.90 m£788.70 m£750.00 m
Stocks£149.50 m£120.80 m£103.50 m
Debtors£106.70 m£93.90 m£99.80 m
Cash & Equivalents£118.40 m£227.40 m£80.30 m
Other Assets£2.00 m£2.70 m£900,000.00
Total Assets£1.21 bn£1.24 bn£1.04 bn
Creditors within 1 year£155.80 m£137.30 m£118.10 m
Creditors after 1 year£425.40 m£462.80 m£414.30 m
Other Liabilities000
Total Liabilities£581.20 m£600.10 m£532.40 m
Net assets£632.90 m£637.50 m£509.10 m
Called up share capital£1.10 m£1.10 m£1.00 m
Share Premium£411.60 m£409.30 m£277.90 m
Profit / Loss£74.00 m£40.90 m£27.80 m
Other Equity£632.90 m£637.50 m£509.10 m
Preference & Minorities000
Total Capital Employed£632.90 m£637.50 m£509.10 m
Debt Ratio£0.33£0.35£0.38
Assets / Equity1.84271.84271.8427
Cash / Equity0.19360.19360.1936
Cash Flow202120202019
Cash from operating activities£89.10 m£106.40 m£81.80 m
Cashflow before financing£34.00 m£225.30 m£61.70 m
Increase in Cash-£102.10 m£143.80 m-£200,000.00
Turnover£608.00 m£515.10 m£481.80 m
Cost of sales£262.10 m£223.50 m£208.70 m
Gross Profit£345.90 m£291.60 m£273.10 m
Operating Profit£84.00 m£52.20 m£39.00 m
Pre-Tax profit£74.00 m£40.90 m£27.80 m

Dechra Pharmaceuticals PLC Company Background

ActivitiesDechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.
Latest Interim Date21 Feb 2022
Latest Fiscal Year End Date6 Sep 2021

Dechra Pharmaceuticals PLC Directors

2021-09-14Mr. Julian HeslopNon-Executive Director
2013-10-17Mr. Neil W WarnerNon-Executive Director
2009-01-09Mr. Malcolm McDonald Diamond MBENon-Executive Director
2019-09-05Mr. Richard John CottonExecutive Director,Chief Financial Officer
2022-06-13Mr. Ian David PageExecutive Director,Chief Executive
2016-10-21Mr. Michael RedmondNon-Executive Director,Chairman
2021-12-29Mr. William Anthony RiceNon-Executive Director,Chairman
2021-09-14Ms. Ishbel Jean Stewart MacphersonNon-Executive Director,Senior Independent Non-Executive Director
2015-09-09Ms. Zoe GouldingCompany Secretary
2012-10-19Mr. Simon David EvansExecutive Director,Group Finance Director
2014-09-15Mr. Edwin Thomas William Torr Executive Director,MD, Dechra Veterinary Products Europe
2012-07-09Mr. Bryan Geoffrey MortonNon-Executive Director
2016-04-08Dr. Christopher Gareth Joseph RichardsNon-Executive Director
2022-04-05Ms. Alison Elizabeth Platt Non-Executive Director,Chairman
2021-10-06Mr. Paul SandlandExecutive Director,Chief Financial Officer
2021-09-22Mr. Anthony GriffinExecutive Director,Managing Director, Dechra Veterinary Products EU
2017-09-05Ms. Anne-Francoise NesmesExecutive Director,Chief Financial Officer
2021-09-14Dr. Lawson MacartneyNon-Executive Director
2021-09-14Ms. Lisa BrightNon-Executive Director
2022-02-21Ms. Denise GoodeNon-Executive Director

Dechra Pharmaceuticals PLC Contact Details

Company NameDechra Pharmaceuticals PLC
Address24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, CW9 7UA
Telephone+44 1606814730

Dechra Pharmaceuticals PLC Advisors

AuditorPricewaterhouseCoopers LLP
Phone+44 1212655000
Fax+44 1212655050
BankRoyal Bank of Scotland PLC
RegistrarEquiniti Limited
Remuneration ConsultantDeloitte LLP
Phone+44 2079363000
Fax+44 2075831198
Financial PR AdviserTooleystreet Communications
SolicitorDLA Piper LLP
Phone+44 8700111111
Fax+44 1212625794
StockbrokerInvestec Securities
Phone+44 2075974000
Fax+44 2075974070
Financial AdviserInvestec Investment Banking
Phone +44 2075974000
Fax+44 20 75974070
BankBarclays Bank PLC